Representative Lisa C. McClain (R-Michigan) recently sold shares of Baxter International Inc. (NYSE:BAX) as part of a series of transactions involving various stocks. According to a filing made public on September 12, McClain sold between $1,001 and $15,000 in Baxter shares on August 4, 2025. The transaction was conducted through her Charles Schwab brokerage account.
In addition to the Baxter transaction, McClain made several other notable trades around the same time. These included the sale of shares in Taiwan Semiconductor Manufacturing (NYSE:TSM) valued between $50,001 and $100,000 on August 28, 2025. She also purchased shares of ACI Worldwide (NASDAQ:ACIW) and HCA Healthcare (NYSE:HCA), each valued between $1,001 and $15,000, on August 19, 2025.
Baxter International’s stock performance has seen fluctuations recently, opening at $23.88 on Wednesday. The company features a current ratio of 2.30 and a quick ratio of 1.49, alongside a debt-to-equity ratio of 1.30. Over the past year, Baxter’s stock has reached a low of $21.33 and a high of $40.49. The company’s market capitalization stands at approximately $12.27 billion, with a price-to-earnings ratio of -79.60.
Baxter International released its quarterly earnings results on July 31, 2025, reporting $0.59 earnings per share (EPS), which fell short of analysts’ expectations of $0.60. The company recorded revenue of $2.81 billion, slightly below the anticipated $2.82 billion. Despite these figures, Baxter reported a year-over-year revenue increase of 4.3%. The firm has set guidance for Q3 2025 EPS between 0.580 and 0.620.
Dividend Announcement and Analyst Ratings
Baxter International also announced a quarterly dividend of $0.17 per share, payable on October 1, 2025. Investors of record on August 29, 2025 will receive this dividend, reflecting an annualized yield of 2.8%. Notably, the company’s payout ratio is currently at -226.67%.
Analysts have recently adjusted their ratings on Baxter shares. Wells Fargo & Company lowered its target price from $33.00 to $24.00 with an “equal weight” rating. Similarly, UBS Group reduced its price target from $35.00 to $24.00, maintaining a “neutral” rating. Evercore ISI and Barclays also adjusted their forecasts, with price targets now ranging from $24.00 to $42.00.
As it stands, three analysts have rated Baxter International as a Buy, six have assigned a Hold rating, and one has issued a Sell rating. The average price target among analysts is currently $30.11.
Institutional Trading Activity
Recent data indicates significant activity from institutional investors regarding Baxter shares. Mufg Securities Americas Inc. purchased a new position valued at approximately $220,000 in the fourth quarter. Raiffeisen Bank International AG and Public Employees Retirement System of Ohio also made notable investments, with positions valued at $2,193,000 and $5,102,000, respectively.
Approximately 90.19% of Baxter International’s stock is held by hedge funds and other institutional investors, reflecting strong institutional interest in the medical instruments supplier.
Lisa C. McClain, who represents Michigan’s 9th Congressional District, assumed office on January 3, 2023, and is currently seeking re-election for the 2026 election. Having a background in business administration, she has founded and led various initiatives, including the North End Support Team.
Baxter International Inc. operates globally, providing a diverse range of healthcare products through segments such as Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company is known for its innovation in medical devices and therapies, making it a significant player in the healthcare sector.
